独家直击！美国“华人女船王”赵安吉车祸溺亡案最新细节披露：酒驾或成事故主因

美国“华人女船王”赵安吉车祸溺亡案最新细节披露：酒驾或成事故主因

2024年3月21日 - 美国得克萨斯州布兰科县警方近日公布了关于“华人女船王”赵安吉车祸溺亡案的最新调查结果。据悉，赵安吉当时驾驶特斯拉Model X SUV在私人牧场内行驶时，因醉酒驾驶导致车辆失控，冲入池塘溺亡。

血检结果显示赵安吉血液中酒精含量超标

警方表示，赵安吉的血液酒精浓度为0.233克/100毫升，是得克萨斯州法定醉驾标准（0.08克/100毫升）的三倍多。这一结果基本证实了赵安吉系酒驾导致事故的推测。

事故发生经过回顾

2月10日晚，赵安吉在位于得克萨斯州的一处私人牧场内与朋友们聚餐庆祝农历新年。聚会结束后，赵安吉独自驾驶特斯拉Model X SUV准备返回位于牧场内的主宅休息。

由于当晚天气寒冷，赵安吉选择放弃步行而驾车前往。然而，在距离主宅仅4分钟车程的路上，意外发生了。

据赵安吉的一位朋友透露，两人在事故发生前通话约8分钟。当时，赵安吉正准备掉头时，误将前进挡挂为倒车挡，导致车辆失控冲出路基，翻入池塘。

由于池塘水位不断上涨，赵安吉未能及时逃出车内，最终溺亡。

家属和朋友对赵安吉的突然离世深表悲痛

赵安吉的父亲、著名美籍华人航运业巨头赵锡成在声明中表示，他对女儿的离世感到无比悲痛。他称赵安吉从小就对航运事业表现出浓厚的兴趣，并在接管家族企业后带领公司取得了长足的发展。

赵安吉的姐姐、美国前交通部长赵小兰也在声明中表达了对妹妹的哀悼。她称赵安吉是一位才华横溢、热心公益的女性，她的离去是整个家族和社会的一大损失。

赵安吉的意外离世也引发了人们对酒驾危害的再次关注

美国国家公路交通安全管理局（NHTSA）的数据显示，2020年美国有超过3.8万人在交通事故中丧生，其中约三分之一与酒驾有关。

NHTSA呼吁驾驶员应始终遵守交通法规，切勿酒后驾车，并建议乘客对酒驾司机进行劝阻或报警。

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.